Zymergen

Closed

Biology-based materials for a better world

Public · Emeryville, United States · Founded 2013 · $928.1M raised

Employees
501–1000
Founded
2013
Business Model
B2B
Total Funding
$928.1M
Last Round
$300.0M Series DSep 2020
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Zymergen was founded in 2013 in Emeryville, California as a biomanufacturing company using AI, machine learning, robotics, and synthetic biology to engineer microbes for the production of novel materials and chemicals. The company raised over $900 million before going public in April 2021. Ginkgo Bioworks acquired Zymergen in October 2022 for approximately $300 million, integrating its software, data science tools, and automation capabilities.

Summary

Zymergen is an Advanced Materials company based in Emeryville, United States, founded in 2013. It has raised $928.1M in total across 6 rounds, most recently a $300.0M Series D round in Sep 2020. Investors include DCVC (Data Collab), SoftBank and Baillie Gifford.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOApr 2021
$530.0M

Sign up to see all 7 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zymergen on Indexed.vc
<a href="https://indexed.vc/companies/zymergen"><img src="https://indexed.vc/api/badge/company/zymergen" alt="Zymergen on Indexed.vc" width="260" height="76" /></a>